CON vs. MEDP: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical Services sector might want to consider either Concentra Group (CON) or Medpace (MEDP). But which of these two companies is the best option for those looking for undervalued stocks?
Why Concentra (CON) is Poised to Beat Earnings Estimates Again
Concentra (CON) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CON or MEDP: Which Is the Better Value Stock Right Now?
Investors interested in Medical Services stocks are likely familiar with Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
Down -8.49% in 4 Weeks, Here's Why Concentra (CON) Looks Ripe for a Turnaround
Concentra (CON) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
CON vs. MEDP: Which Stock Is the Better Value Option?
Investors with an interest in Medical Services stocks have likely encountered both Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
Has Concentra Group Holdings Parent, Inc. (CON) Outpaced Other Medical Stocks This Year?
Here is how Concentra Group (CON) and Cencora (COR) have performed compared to their sector so far this year.
Concentra (CON) Upgraded to Strong Buy: Here's What You Should Know
Concentra (CON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Value Stocks to Buy for January 10th
UAL, CON and ICFI made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 10, 2024.
Concentra's Post-IPO Trading Levels Based On 'Its Dominant Market Position,' Says Analyst
Concentra Group Holdings Inc CON priced in July its initial public offering of 22.5 million shares at $23.50 per share.
Concentra's High-Quality Business Model Attracts Analyst Attention, Initiates With Buy Rating
Concentra Group Holdings Parent, Inc. CON shares are trading higher today. Deutsche Bank analyst Justin Bowers initiated coverage on the stock with a Buy rating and a price target of $29.
Healthcare firm Concentra shares fall 6% in NYSE debut
U.S. healthcare firm Concentra's shares fell 6% in their debut on the New York Stock Exchange on Thursday, in a sign of investor caution with new listings amid uncertainties over interest-rate cuts.
CON Stock: 7 Things to Know as Concentra Group Starts Trading Today
Concentra Group (NYSE:CON) stock is set to start trading on Thursday after the occupational health services company announced the pricing of shares in its initial public offering ( IPO ). Let's dive into everything investors need to know about Concentra Group starting to trade today below!
